LPTX

Leap Therapeutics, Inc. - Common Stock (LPTX)

About Leap Therapeutics, Inc. - Common Stock (LPTX)

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Details

Daily high

$0.38

Daily low

$0.35

Price at open

$0.37

52 Week High

$4.79

52 Week Low

$0.22

Market cap

15.0M

Dividend yield

0.00%

Volume

109,095

Avg. volume

378,197

P/E ratio

-.21

Leap Therapeutics, Inc. - Common Stock News